Savient Pharma (SVNT) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Join SI Premium – FREE
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) reported Q3 loss of ($0.39), $0.01 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $2.58 million versus the consensus estimate of $3.17 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
- Innovaro (INV) Misses Q2 EPS by 9c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
